Information Technology Services
Compare Stocks
5 / 10Stock Comparison
III vs IBM vs ACN vs CTSH vs INFY
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
Information Technology Services
III vs IBM vs ACN vs CTSH vs INFY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Information Technology Services | Information Technology Services | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $199M | $216.93B | $112.19B | $24.61B | $51.04B |
| Revenue (TTM) | $245M | $68.91B | $72.11B | $21.41B | $19.85B |
| Net Income (TTM) | $9M | $10.75B | $7.68B | $2.23B | $3.21B |
| Gross Margin | 41.2% | 59.0% | 32.0% | 32.1% | 30.0% |
| Operating Margin | 7.3% | 16.4% | 14.8% | 15.7% | 20.3% |
| Forward P/E | 19.7x | 18.6x | 13.0x | 9.1x | 16.5x |
| Total Debt | $71M | $67.15B | $8.18B | $1.57B | $962M |
| Cash & Equiv. | $29M | $13.64B | $11.48B | $1.90B | $2.86B |
III vs IBM vs ACN vs CTSH vs INFY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Information Service… (III) | 100 | 242.4 | +142.4% |
| International Busin… (IBM) | 100 | 193.8 | +93.8% |
| Accenture plc (ACN) | 100 | 89.4 | -10.6% |
| Cognizant Technolog… (CTSH) | 100 | 98.0 | -2.0% |
| Infosys Limited (INFY) | 100 | 138.3 | +38.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: III vs IBM vs ACN vs CTSH vs INFY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
III ranks third and is worth considering specifically for momentum.
- +10.1% vs ACN's -39.1%
IBM is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 7.6%, EPS growth 73.7%, 3Y rev CAGR 3.7%
- 107.8% 10Y total return vs INFY's 73.6%
- 7.6% revenue growth vs III's -1.2%
Among these 5 stocks, ACN doesn't own a clear edge in any measured category.
CTSH is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 0.75, Low D/E 10.5%, current ratio 2.34x
- PEG 0.75 vs INFY's 2.47
- Lower P/E (9.1x vs 16.5x), PEG 0.75 vs 2.47
- Beta 0.75 vs III's 1.48, lower leverage
INFY carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 4 yrs, beta 0.83, yield 4.6%
- Beta 0.83, yield 4.6%, current ratio 2.27x
- 16.2% margin vs III's 3.8%
- 4.6% yield, 4-year raise streak, vs IBM's 2.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.6% revenue growth vs III's -1.2% | |
| Value | Lower P/E (9.1x vs 16.5x), PEG 0.75 vs 2.47 | |
| Quality / Margins | 16.2% margin vs III's 3.8% | |
| Stability / Safety | Beta 0.75 vs III's 1.48, lower leverage | |
| Dividends | 4.6% yield, 4-year raise streak, vs IBM's 2.9% | |
| Momentum (1Y) | +10.1% vs ACN's -39.1% | |
| Efficiency (ROA) | 18.6% ROA vs III's 4.5%, ROIC 31.8% vs 9.7% |
III vs IBM vs ACN vs CTSH vs INFY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
III vs IBM vs ACN vs CTSH vs INFY — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTSH leads in 1 of 6 categories
INFY leads 1 • IBM leads 1 • III leads 0 • ACN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — IBM and INFY each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACN is the larger business by revenue, generating $72.1B annually — 294.7x III's $245M. INFY is the more profitable business, keeping 16.2% of every revenue dollar as net income compared to III's 3.8%. On growth, IBM holds the edge at +9.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $245M | $68.9B | $72.1B | $21.4B | $19.8B |
| EBITDAEarnings before interest/tax | $22M | $15.1B | $12.1B | $3.9B | $4.3B |
| Net IncomeAfter-tax profit | $9M | $10.8B | $7.7B | $2.2B | $3.2B |
| Free Cash FlowCash after capex | $24M | $13.1B | $12.5B | $2.5B | $3.8B |
| Gross MarginGross profit ÷ Revenue | +41.2% | +59.0% | +32.0% | +32.1% | +30.0% |
| Operating MarginEBIT ÷ Revenue | +7.3% | +16.4% | +14.8% | +15.7% | +20.3% |
| Net MarginNet income ÷ Revenue | +3.8% | +15.6% | +10.7% | +10.4% | +16.2% |
| FCF MarginFCF ÷ Revenue | +9.8% | +19.0% | +17.3% | +11.5% | +19.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.9% | +9.5% | +8.3% | +5.8% | +3.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -13.7% | +14.3% | +3.9% | +3.7% | -5.3% |
Valuation Metrics
CTSH leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.4x trailing earnings, CTSH trades at a 48% valuation discount to III's 21.9x P/E. Adjusting for growth (PEG ratio), III offers better value at 0.85x vs INFY's 2.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $199M | $216.9B | $112.2B | $24.6B | $51.0B |
| Enterprise ValueMkt cap + debt − cash | $241M | $270.4B | $108.9B | $24.3B | $49.1B |
| Trailing P/EPrice ÷ TTM EPS | 21.95x | 20.70x | 14.83x | 11.42x | 16.56x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.67x | 18.60x | 12.98x | 9.14x | 16.52x |
| PEG RatioP/E ÷ EPS growth rate | 0.85x | 1.67x | 1.64x | 0.94x | 2.48x |
| EV / EBITDAEnterprise value multiple | 10.78x | 17.62x | 8.60x | 5.95x | 10.59x |
| Price / SalesMarket cap ÷ Revenue | 0.81x | 3.21x | 1.61x | 1.17x | 2.65x |
| Price / BookPrice ÷ Book value/share | 2.22x | 6.70x | 3.53x | 1.67x | 4.64x |
| Price / FCFMarket cap ÷ FCF | 7.96x | 18.74x | 10.32x | 9.48x | 12.49x |
Profitability & Efficiency
INFY leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
IBM delivers a 35.4% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $10 for III. INFY carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to IBM's 2.05x. On the Piotroski fundamental quality scale (0–9), CTSH scores 6/9 vs INFY's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.9% | +35.4% | +23.9% | +14.8% | +29.6% |
| ROA (TTM)Return on assets | +4.5% | +7.1% | +11.8% | +10.9% | +18.6% |
| ROICReturn on invested capital | +9.7% | +9.8% | +26.8% | +18.7% | +31.8% |
| ROCEReturn on capital employed | +10.6% | +9.5% | +24.9% | +21.1% | +33.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.74x | 2.05x | 0.25x | 0.10x | 0.09x |
| Net DebtTotal debt minus cash | $42M | $53.5B | -$3.3B | -$326M | -$1.9B |
| Cash & Equiv.Liquid assets | $29M | $13.6B | $11.5B | $1.9B | $2.9B |
| Total DebtShort + long-term debt | $71M | $67.2B | $8.2B | $1.6B | $962M |
| Interest CoverageEBIT ÷ Interest expense | 4.38x | 6.41x | 40.67x | 107.78x | 90.32x |
Total Returns (Dividends Reinvested)
IBM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IBM five years ago would be worth $19,024 today (with dividends reinvested), compared to $7,046 for ACN. Over the past 12 months, III leads with a +10.1% total return vs ACN's -39.1%. The 3-year compound annual growth rate (CAGR) favors IBM at 26.8% vs ACN's -9.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -24.5% | -20.1% | -29.4% | -35.7% | -30.7% |
| 1-Year ReturnPast 12 months | +10.1% | -6.1% | -39.1% | -31.7% | -26.0% |
| 3-Year ReturnCumulative with dividends | -5.8% | +103.6% | -25.5% | -9.8% | -7.5% |
| 5-Year ReturnCumulative with dividends | +2.3% | +90.2% | -29.5% | -22.9% | -19.0% |
| 10-Year ReturnCumulative with dividends | +22.0% | +107.8% | +89.9% | +0.0% | +73.6% |
| CAGR (3Y)Annualised 3-year return | -2.0% | +26.8% | -9.3% | -3.4% | -2.6% |
Risk & Volatility
Evenly matched — IBM and CTSH each lead in 1 of 2 comparable metrics.
Risk & Volatility
CTSH is the less volatile stock with a 0.75 beta — it tends to amplify market swings less than III's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IBM currently trades 71.2% from its 52-week high vs INFY's 41.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.48x | 1.03x | 0.85x | 0.75x | 0.83x |
| 52-Week HighHighest price in past year | $6.45 | $324.90 | $325.71 | $87.03 | $30.00 |
| 52-Week LowLowest price in past year | $3.74 | $220.72 | $173.52 | $50.81 | $12.16 |
| % of 52W HighCurrent price vs 52-week peak | +64.7% | +71.2% | +55.3% | +59.7% | +41.9% |
| RSI (14)Momentum oscillator 0–100 | 50.8 | 38.0 | 33.5 | 23.6 | 41.0 |
| Avg Volume (50D)Average daily shares traded | 230K | 5.4M | 5.7M | 5.9M | 16.2M |
Analyst Outlook
Evenly matched — IBM and INFY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: III as "Buy", IBM as "Hold", ACN as "Buy", CTSH as "Hold", INFY as "Hold". Consensus price targets imply 66.4% upside for ACN (target: $300) vs 31.9% for III (target: $6). For income investors, INFY offers the higher dividend yield at 4.62% vs CTSH's 2.44%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $5.50 | $309.64 | $299.92 | $83.33 | $16.90 |
| # AnalystsCovering analysts | 2 | 50 | 53 | 51 | 40 |
| Dividend YieldAnnual dividend ÷ price | +4.4% | +2.9% | +3.2% | +2.4% | +4.6% |
| Dividend StreakConsecutive years of raises | 0 | 30 | 14 | 9 | 4 |
| Dividend / ShareAnnual DPS | $0.18 | $6.59 | $5.85 | $1.27 | $0.58 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.7% | 0.0% | +4.1% | +5.6% | 0.0% |
CTSH leads in 1 of 6 categories (Valuation Metrics). INFY leads in 1 (Profitability & Efficiency). 3 tied.
III vs IBM vs ACN vs CTSH vs INFY: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is III or IBM or ACN or CTSH or INFY a better buy right now?
For growth investors, International Business Machines Corporation (IBM) is the stronger pick with 7.
6% revenue growth year-over-year, versus -1. 2% for Information Services Group, Inc. (III). Cognizant Technology Solutions Corporation (CTSH) offers the better valuation at 11. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Information Services Group, Inc. (III) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — III or IBM or ACN or CTSH or INFY?
On trailing P/E, Cognizant Technology Solutions Corporation (CTSH) is the cheapest at 11.
4x versus Information Services Group, Inc. at 21. 9x. On forward P/E, Cognizant Technology Solutions Corporation is actually cheaper at 9. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cognizant Technology Solutions Corporation wins at 0. 75x versus Infosys Limited's 2. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — III or IBM or ACN or CTSH or INFY?
Over the past 5 years, International Business Machines Corporation (IBM) delivered a total return of +90.
2%, compared to -29. 5% for Accenture plc (ACN). Over 10 years, the gap is even starker: IBM returned +107. 8% versus CTSH's +0. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — III or IBM or ACN or CTSH or INFY?
By beta (market sensitivity over 5 years), Cognizant Technology Solutions Corporation (CTSH) is the lower-risk stock at 0.
75β versus Information Services Group, Inc. 's 1. 48β — meaning III is approximately 97% more volatile than CTSH relative to the S&P 500. On balance sheet safety, Infosys Limited (INFY) carries a lower debt/equity ratio of 9% versus 2% for International Business Machines Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — III or IBM or ACN or CTSH or INFY?
By revenue growth (latest reported year), International Business Machines Corporation (IBM) is pulling ahead at 7.
6% versus -1. 2% for Information Services Group, Inc. (III). On earnings-per-share growth, the picture is similar: Information Services Group, Inc. grew EPS 216. 7% year-over-year, compared to 0. 0% for Infosys Limited. Over a 3-year CAGR, INFY leads at 5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — III or IBM or ACN or CTSH or INFY?
Infosys Limited (INFY) is the more profitable company, earning 16.
4% net margin versus 3. 8% for Information Services Group, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INFY leads at 21. 1% versus 7. 3% for III. At the gross margin level — before operating expenses — IBM leads at 59. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is III or IBM or ACN or CTSH or INFY more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Cognizant Technology Solutions Corporation (CTSH) is the more undervalued stock at a PEG of 0. 75x versus Infosys Limited's 2. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Cognizant Technology Solutions Corporation (CTSH) trades at 9. 1x forward P/E versus 19. 7x for Information Services Group, Inc. — 10. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACN: 66. 4% to $299. 92.
08Which pays a better dividend — III or IBM or ACN or CTSH or INFY?
All stocks in this comparison pay dividends.
Infosys Limited (INFY) offers the highest yield at 4. 6%, versus 2. 4% for Cognizant Technology Solutions Corporation (CTSH).
09Is III or IBM or ACN or CTSH or INFY better for a retirement portfolio?
For long-horizon retirement investors, Cognizant Technology Solutions Corporation (CTSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
75), 2. 4% yield). Both have compounded well over 10 years (CTSH: +0. 0%, III: +22. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between III and IBM and ACN and CTSH and INFY?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: III is a small-cap income-oriented stock; IBM is a large-cap quality compounder stock; ACN is a mid-cap deep-value stock; CTSH is a mid-cap deep-value stock; INFY is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.